Key Events This Week
18 May: Stock opens at Rs.187.80, down 3.32%
20 May: Intraday high of Rs.203.90 with 7.74% surge
21 May: Price momentum peaks with 12.01% gain
22 May: Intraday low of Rs.197.05 amid 7.68% drop
Jun 12, 03:31 PM
BSE+NSE Vol: 2.75 lacs

Dishman Carbogen Amcis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Dishman Carbogen Amcis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 February 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Dishman Carbogen Amcis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 February 2026, reflecting a reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 08 June 2026, providing investors with an up-to-date view of the stock’s position.
Read full news article
Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid mixed signals.
Read full news article
Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 1.18%, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment amid ongoing market volatility.
Read full news article
Dishman Carbogen Amcis Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators such as MACD, RSI, and moving averages. Despite a recent downgrade to a Strong Sell rating, the stock’s technical profile reveals nuanced market dynamics that investors should carefully consider.
Read full news article
Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent 2.17% gain in daily price, the company’s overall technical and fundamental outlook remains cautious, as indicated by its downgrade to a Strong Sell rating by MarketsMOJO on 12 January 2026.
Read full news article
Dishman Carbogen Amcis Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news article